2m 2m 2m 2m 2m 2m 2m
Theravance Bioph (TBPH)
NASDAQ
$15.89+$0.31 (+1.99%)
Price as of Jun 03, 2026 4:10 PM EDT- $1.2BMarket Cap
- 40.11%1-Year Change
- BiotechnologyIndustry
Theravance Bioph (TBPH)
$15.89+$0.31 (+1.99%)
TBPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.58 | ||
Change | -$0.36 (-2.26%) | ||
Open | $15.83 | ||
High | $15.83 | ||
Low | $15.52 | ||
Previous Close | $15.94 | ||
Volume | 814,823 | ||
30-Day Average Volume | 381,455 | ||
1-Week Change | -5.06% | ||
1-Month Change | -7.21% | ||
1-Year Change | 40.11% | ||
3-Year Change | 40.49% | ||
5-Year Change | -8.46% | ||
Fundamentals | |||
Shares Outstanding | 73.5M | ||
Total Assets | $472.3M | ||
Market Cap | $1.2B | ||
Enterprise Value | $891.8M | ||
Period: QTR TTM FY | |||
Revenue | $17.7M | ||
Net Income | -$4.9M | ||
Free Cash Flow | $73.3M | ||
EBIT | -$6.5M | ||
EBITDA | -$6.1M | ||
Net Working Capital | $385.9M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -146 | ||
Enterprise Value/Revenue | 50 | ||
P/B | 4 | ||
P/E | -161 | ||
PEG | 1 | ||
Price/Free Cash Flow | 16 | ||
Price/Operating Cash Flow | 16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue